Cycletherapy Counseling Services Pc | |
42534 Highway 23 Elwood NE 68937-5632 | |
(308) 785-2064 | |
Not Available |
Full Name | Cycletherapy Counseling Services Pc |
---|---|
Speciality | Counselor - Professional |
Location | 42534 Highway 23, Elwood, Nebraska |
Authorized Official Name and Position | David C Blessing (PRESIDENT) |
Authorized Official Contact | 3087852064 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Cycletherapy Counseling Services Pc 42534 Highway 23 Elwood NE 68937-5632 Ph: (308) 785-2064 | Cycletherapy Counseling Services Pc 42534 Highway 23 Elwood NE 68937-5632 Ph: (308) 785-2064 |
NPI Number | 1972683282 |
---|---|
Provider Enumeration Date | 10/17/2006 |
Last Update Date | 10/10/2011 |
Identifier | Type | State | Issuer |
---|---|---|---|
1972683282 | NPI | - | NPPES |
50770434026 | Medicaid | NE | |
50770434027 | Medicaid | NE | |
24151 | Other | NE | MIDLANDS CHOICE |
84238 | Other | NE | BLUE CROSS/BS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YP2500X | Counselor - Professional | 1742 (Nebraska) | Primary |
News Archive
Stroke-induced inflammation is both a blessing and a curse. Some of the inflammatory processes help heal the damaged brain after treatment, but others severely damage neurons and whole-body function.
Jason Vale, president of the New York-based Christian Brothers Contracting Corp., was sentenced on June 18, 2004 to 63 months in prison and 3 years of supervised release by a United States District Court in the Eastern District of New York.
A preliminary report suggests that cell-free fetal messenger RNA (ribonucleic acid) can be extracted from amniotic fluid (fluid around the fetus), and then be analyzed to study gene expression changes that may reflect the well-being of the fetus, according to a paper in the February 16 issue of JAMA, a theme issue on medical applications of biotechnology.
New research from the University of East Anglia (UEA) recommends changes to the system which sees drug companies strike deals with competitors to stop them producing cheaper generic alternatives.
› Verified 9 days ago